| # | Drug | Count |
|---|---|---|
| 0 | INTERFERON BETA-1A | 28 |
| 1 | INTERFERON BETA-1B | 15 |
| 2 | TRIAMCINOLONE ACETONIDE | 9 |
| 3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 9 |
| 4 | ASFOTASE ALFA | 6 |
| 5 | LEVOTHYROXINE SODIUM | 6 |
| 6 | INSULIN LISPRO | 5 |
| 7 | PREDNISOLONE | 5 |
| 8 | PREDNISOLONE ORAL | 5 |
| 9 | PREDNISOLONE ORAL SOLUTION | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 1 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 2 | INTERFERON BETA-1B | 15 | 0.0008 |
| 3 | TESAMORELIN | 1 | 0.0006 |
| 4 | ASFOTASE ALFA | 6 | 0.0006 |
| 5 | CABOTEGRAVIR AND RILPIVIRINE | 3 | 0.0005 |
| 6 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 9 | 0.0004 |
| 7 | CALCITONIN SALMON | 1 | 0.0003 |
| 8 | TRIAMCINOLONE ACETONIDE | 9 | 0.0003 |
| 9 | CABERGOLINE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interferon beta [EPC] | 30 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | GLP-1 Receptor Agonist [EPC] | 6 |
| 3 | Insulin Analog [EPC] | 6 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 6 |
| 5 | Benzodiazepine [EPC] | 5 |
| 6 | Anti-IgE [EPC] | 3 |
| 7 | Insulin [EPC] | 3 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 9 | Potassium Channel Blocker [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 6 | 0.0006 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 3 | Interferon beta [EPC] | 30 | 0.0002 |
| 4 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 6 | Insulin [EPC] | 3 | 0.0001 |
| 7 | Potassium Channel Blocker [EPC] | 3 | 0.0000 |
| 8 | Anti-IgE [EPC] | 3 | 0.0000 |
| 9 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |